Aug 01, 2019 / 12:30PM GMT
Operator
Good day, ladies and gentlemen, and welcome to the Q2 2019 Blueprint Medicines Corp Conference Call. (Operator Instructions)
I would now like to introduce your host for today's conference, Kristin Hodous of Blueprint Medicines. Ma'am, you may begin.
Kristin Hodous - Blueprint Medicines Corporation - Senior Manager of IR
Thank you, operator. Good morning, everyone. This is Kristin Hodous of Blueprint Medicines, and welcome to Blueprint Medicines Second Quarter 2019 Financial and Operating Results Conference Call. This morning, we issued a press release, which outlines the topics we plan to discuss today. You can access the press release as well as the slides that we'll be reviewing today by going to the Investors section of our website at www.blueprintmedicines.com.
Today, on our call, Jeff Albers, our Chief Executive Officer, will discuss our second quarter business highlights; Christy Rossi, our Chief Commercial Officer, will provide an update on our commercial plans;
Q2 2019 Blueprint Medicines Corp Earnings Call Transcript
Aug 01, 2019
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers